Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

BC

Biopol Chemicals IPO

Listed SME NSE SME · Specialty Chemicals

Price Band

₹102.0–108.0

Issue Size

₹31.26 Cr

Lot Size

1,200 shares

Min Investment

₹259,200

2 LOTS MIN

GMP

Grey Market Premium — the unofficial premium buyers are currently willing to pay over the issue price once this IPO lists. It's an informal market estimate, not guaranteed, and can move daily right up to listing day. Learn more: GMP vs Kostak vs Sauda →

+₹1.0 (0.93%)

Issue Price

₹108.0

Biopol Chemicals IPO AI Summary

  • Biopol Chemicals IPO is listed on NSE SME in the Specialty Chemicals sector.
  • Price band: ₹102.0–₹108.0 per share, lot size 1,200 shares (min. investment ₹259,200, 2 lots minimum).
  • Subscription window: 06 Feb–10 Feb 2026, listing on 13 Feb 2026.
  • Current GMP is +₹1.0 (0.93%), an estimated listing price of ₹109 — unofficial and can change daily.

Biopol Chemicals Limited is a specialty chemicals manufacturer with a diverse product portfolio and a strong domestic and export presence. The company is looking to raise funds through its IPO for various strategic purposes, including land acquisition and debt repayment.

TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.

Important Dates

IPO Open Date
Fri, 06 Feb 2026
IPO Close Date
Tue, 10 Feb 2026
Allotment Date
Wed, 11 Feb 2026
Refund Initiation
Thu, 12 Feb 2026
Credit of Shares
Thu, 12 Feb 2026
Listing Date
Fri, 13 Feb 2026
Listing Price
₹109.0 +0.93%

Subscription Status

Subscription data unavailable

Biopol Chemicals IPO Grey Market Premium (GMP) Today

GMP

+₹1.0

GMP %

+0.93%

Est. Listing

₹109.0

Updated: 14 Jul 2026 15:52

About the Company

Biopol Chemicals Limited is engaged in the manufacturing and distribution of specialty chemicals categorized into silicones, emulsifiers, biochemicals, and polyelectrolytes. Its product portfolio comprises 66 products, including 40 silicone-based products, 5 emulsifier-based products, 15 biochemical products, and 6 polyelectrolyte products. These products find applications across multiple industries, including textiles, home care, agriculture, and industrial chemicals. In addition to manufacturing, the company provides technical consultancy services, assisting clients in areas such as textile processing, dye manufacturing, and industrial chemical formulation. Biopol operates on a B2B model, serving institutional clients through both direct sales and a distributor network, with a strong domestic presence across West Bengal, Gujarat, Maharashtra, Tamil Nadu, and Karnataka, and exports primarily to Bangladesh, a major hub for textile and apparel manufacturing. Competitive Strengths Order Book Manufacturing Unit Quality Certification and Quality Assurance Strategic presence in Gujarat and West Bengal Experienced Promoter and Management Team Export operations in Bangladesh

Company Financials (₹ Cr)

As of 2025-12-31

Period Ended 31 Dec 2025 31 Mar 2025 31 Mar 2024
Assets 48.88 31.48 17.56
Total Income 48.97 49.15 17.43
Profit After Tax 6.00 4.33 2.96
EBITDA 8.99 6.53 4.43
NET Worth 19.54 13.53 9.20
Reserves and Surplus 11.63 5.62 1.29
Total Borrowing 14.92 7.69 3.58

Key Ratios

EPS

₹5.47

NAV

₹17.12

ROE

38.10%

ROCE

30.57%

RoNW

32.00%

P/B Value

6.31

P/E Ratio

19.73

Market Cap

₹116.70 Cr

PAT Margin

8.84%

Debt/Equity

0.57

Promoters

Santanu Sarkar and Vedant Sarkar

Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Acquisition of industrial land 12.26 2 Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies 11.10 3 General Corporate Purposes 4.04 4 Issue Expenses 3.85 Total 31.26

IPO Evaluation

Generated 23 Sep 2026

Revenue Trend

Total income was ₹17.43 Cr in the period ending 31 Mar 2024, rising to ₹49.15 Cr by 31 Mar 2025. However, it slightly decreased to ₹48.97 Cr by 31 Dec 2025, though this is a 9-month figure, not a full year, so isn't directly comparable.

Profit Trend

Profit After Tax was ₹2.96 Cr in the period ending 31 Mar 2024, increasing to ₹4.33 Cr by 31 Mar 2025. It further rose to ₹6.00 Cr by 31 Dec 2025, indicating a consistent upward trend in profitability.

Grey Market Premium, Explained

The Grey Market Premium (GMP) indicates the expected listing price of an IPO based on unofficial trading before it officially lists on the stock exchange. A positive GMP suggests that the IPO may list at a price higher than the issue price, while a negative GMP indicates the opposite.

Who This IPO Suits

Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against the company's fundamentals, market position, and growth potential.

Who May Want to Wait

Investors with a low-risk appetite or those who prefer stable, established companies may want to avoid IPOs in the specialty chemicals sector, which can be more volatile.

IPO Timeline, Explained

The IPO opens for subscription on 6 February 2026 and closes on 10 February 2026. Allotment of shares is expected on 11 February 2026, with the listing date set for 13 February 2026.

Listing Gains — The Risk

Listing-day gains can be unpredictable and depend on various factors, including market sentiment and demand for the stock. Investors should be aware that while some IPOs experience significant gains on their first day of trading, others may not perform as expected.

This evaluation is generated from Biopol Chemicals's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.

Frequently Asked Questions

What is Biopol Chemicals IPO GMP today?

Biopol Chemicals IPO GMP today is +₹1.0 (0.93%), indicating an estimated listing price of ₹109. GMP is an unofficial grey-market indicator and can change daily.

What is the price band of Biopol Chemicals IPO?

The price band of Biopol Chemicals IPO is ₹102.0–₹108.0 per share.

When does Biopol Chemicals IPO open and close?

Biopol Chemicals IPO opens on 06 February 2026 and closes on 10 February 2026.

When does Biopol Chemicals IPO list on the stock exchange?

Biopol Chemicals IPO listed on 13 February 2026 at ₹109.0.

What is the lot size for Biopol Chemicals IPO?

The lot size for Biopol Chemicals IPO is 1200 shares, requiring a minimum investment of ₹259,200 (2 lots).

What is the price band for the Biopol Chemicals IPO?

The price band for the Biopol Chemicals IPO is ₹102.0 to ₹108.0.

What is the minimum investment required for this IPO?

The minimum investment required for this IPO is ₹259,200, which corresponds to a lot size of 1200 shares.

When does the Biopol Chemicals IPO open and close?

The IPO opens on 6 February 2026 and closes on 10 February 2026.

What does GMP mean?

GMP stands for Grey Market Premium, which indicates the expected listing price of an IPO based on unofficial trading before it officially lists.

When is the listing date for Biopol Chemicals?

The listing date for Biopol Chemicals is set for 13 February 2026.

Issue Details

Issue Type SME Book Built
Issue Size ₹31.26 Cr
Price Band ₹102.0 – ₹108.0
Issue Price ₹108.0
Lot Size 1,200 shares
Min Investment ₹259,200 (2 lots minimum)
Exchange NSE SME
Sector Specialty Chemicals
Open Date 06 Feb 2026
Close Date 10 Feb 2026
Allotment 11 Feb 2026
Listing Date 13 Feb 2026

Investor Allocation

QIB (Institutional) 50%
NII / HNI 15%
Retail (RII) 35%

Registrar

Bigshare Services Pvt.Ltd.

Lead Managers / Book Running

Smart Horizon Capital Advisors Pvt.Ltd.

IPO Timeline

Open

06 Feb 2026

Close

10 Feb 2026

Allotment

11 Feb 2026

Listing

13 Feb 2026

Community Sentiment

What are other investors planning for Biopol Chemicals?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.